Old Second Bancorp declares cash dividend of $0.08 per share
Old Second Bancorp Inc. announces a cash dividend of $0.08 per share, reflecting financial stability and enhancing shareholder value.
Oncolytics Biotech reveals REO 033 trial details for ESMO 2026
Oncolytics Biotech announces REO 033 trial details to be presented at ESMO 2026, showcasing potential advancements in colorectal cancer treatment.
Microbot Medical sets annual meeting, announces patent wins
Microbot Medical Inc. announces its annual meeting date and new patent approvals, signaling growth in the surgical instruments sector.
Planet Green Holdings reports unusual trading activity
Planet Green Holdings Corp. addresses unusual trading activity in its stock, raising questions about market conditions in the canned and preserved food sector.
Blue Owl Capital Corp II Declares $0.62 Per Share Distribution
Blue Owl Capital Corp II announces a $0.62 per share capital distribution, exceeding its previous targets and showcasing strong portfolio management.
Arcus Biosciences Presents New Data on Casdatifan for ccRCC
Arcus Biosciences announces new data from its ARC-20 study on casdatifan, showing promising results for treating clear cell renal cell carcinoma.
StubHub appoints Andrew Raab to Board of Directors
StubHub Holdings, Inc. enhances its Board with Andrew Raab's appointment, bringing valuable capital markets experience to the team.
Lipocine Inc. Updates Corporate Presentation for Investors
Lipocine Inc. updates its corporate presentation, enhancing investor engagement and transparency in the pharmaceutical preparations industry.
Odyssey Therapeutics Reports Positive Phase 2a Results for OD-001
Odyssey Therapeutics announces encouraging Phase 2a trial results for OD-001, enhancing its standing in the biological products industry.
CRISPR Therapeutics appoints Andrew J. Silver as CFO
CRISPR Therapeutics AG has appointed Andrew J. Silver as its new Chief Financial Officer, effective immediately, strengthening its financial leadership.
Rapport Therapeutics announces positive Phase 2 trial results
Rapport Therapeutics reports positive results from its Phase 2 trial of RAP-219 for bipolar mania, paving the way for Phase 3 trials in 2027.
Aquestive Therapeutics Amends Bylaws to Simplify Governance
Aquestive Therapeutics has updated its bylaws, altering stockholder nomination processes to enhance governance flexibility.
West Coast Community Bancorp Declares Quarterly Cash Dividend
West Coast Community Bancorp announces a $0.29 quarterly cash dividend, marking a $0.04 increase from the previous dividend, reflecting financial stability.
Federal Home Loan Bank of Des Moines Names New Chief Business Officer
Brett L.A. Manning appointed as Chief Business Officer of Federal Home Loan Bank of Des Moines, effective immediately.
NexMetals Mining updates Mineral Resource Estimate for Selebi
NexMetals Mining Corp. announces an updated Mineral Resource Estimate for Selebi North, reflecting potential growth in its mining assets.
Aehr Test Systems Holds Annual Meeting, Elects Directors
Aehr Test Systems' shareholders voted on key proposals at the Annual Meeting, including the election of directors and ratification of auditors.
Ohio Valley Banc Corp. Declares Quarterly Cash Dividend
Ohio Valley Banc Corp. announces a quarterly cash dividend of $0.25 per share, payable on November 10, 2026, reflecting financial stability.
USCB Financial Holdings announces quarterly cash dividend
USCB Financial Holdings declares a quarterly cash dividend of $0.125 per share, payable on December 4, 2026, reflecting its commitment to shareholders.
Usio, Inc. Announces Upcoming Investor Presentations
Usio, Inc. plans to present at two investor conferences, showcasing its commitment to engaging with stakeholders and enhancing visibility in the banking sector.
Ball Corp announces leadership changes in Beverage Packaging
Ball Corp reveals leadership transitions in its Beverage Packaging division, with Carey Causey taking over as President for North and Central America.